Super V3 Investment Limited Partnership Jafco, 10% Owner at Eleven Biotherapeutics, Inc. (EBIO), sold 17,900 shares at $11.62 ($208K) on 2015-02-02, disclosed to the SEC on 2015-02-03.
Open-market sale of $208k EBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| TCON | SELL | 2015-10-13 | $32K | — | Filing → |
| TCON | SELL | 2015-10-08 | $221K | — | Filing → |
| TCON | SELL | 2015-10-06 | $152K | — | Filing → |